Detection of telomerase inhibitors based on g-quadruplex ligands by a modified telomeric repeat amplification protocol assay.
The telomeric repeat amplification protocol (TRAP) is commonly used to evaluate telomerase activity in tissues or cell extracts and also to determine the inhibitory properties of small molecules against telomerase. The recent discovery of G-quadruplex ligands as potent telomerase inhibitors prompted us to examine the accuracy of TRAP to be used to screen such class of molecules. Because of the specific feature of the TS primer, TRAP only allows the detection of G-quadruplex-induced telomerase inhibition after the synthesis of four TTAGGG repeats by telomerase and may thus lead to misinterpretations during screening assays. We have developed a TRAP-G4 assay that will allow the unambiguous detection of the inhibitory properties of a G-quadruplex ligand on telomerase activity and is able to discriminate them from other telomerase inhibitors.
Gomez
Dennis
D
Laboratoire de Physiologie Humaine, CNRS UMR 6142, UFR de Pharmacie, Université de Reims Champagne-Ardenne, 51096 Reims Cedex, France.
Mergny
Jean-Louis
JL
Riou
Jean-François
JF
D004247:DNA / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D054856:G-Quadruplexes; D005784:Gene Amplification; D006147:Guanine / Q000378:metabolism; D006801:Humans; D008024:Ligands; D016133:Polymerase Chain Reaction / Q000379:methods; D012091:Repetitive Sequences, Nucleic Acid; D019914:Taq Polymerase / Q000037:antagonists & inhibitors; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016615:Telomere / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D014227:Triazines / Q000494:pharmacology
D004791:Enzyme Inhibitors; D008024:Ligands; D014227:Triazines; D006147:Guanine; D004247:DNA; D019914:Taq Polymerase; D019098:Telomerase